October 8, 2011

Monoclonal Gammopathy of Undetermined Significance Does Not Affect Outcomes in Patients Undergoing Solid Organ Transplants

.   .   

Monoclonal gammopathy of unknown significance (MGUS) is often benign but can progress to myeloma in some cases. Whether immunosuppression increases the risk of progression is unknown. In this retrospective study, MGUS was not associated with progression to myeloma, amyloid or lymphoma post-transplant. MGUS should not be considered a contraindication to transplant.

Related Articles:

Renal Transplantation

Comments are closed.